Last November at Doha the Member States of the WTO instructed the TRIPS Council to find a solution before the end of 2002 making it possible for generic producing countries to export generics to countries which aren’t producing themselves.
Now the European Commission and the Unites States of America, which play down the importance of universally recognized public health needs, run counter to the spirit of the Doha declaration on TRIPS and Public Health, and restrict the export of generics by all possible means.
Health care and access to medication are fundamental rights, that neither industry nor the rich countries should be allowed to oppose.
All the countries wishing to use generics should be in a position to do so as easily as if they were able to produce them on their own.
